000 | 01488 a2200373 4500 | ||
---|---|---|---|
005 | 20250515190109.0 | ||
264 | 0 | _c20100406 | |
008 | 201004s 0 0 eng d | ||
022 | _a1129-2377 | ||
024 | 7 |
_a10.1007/s10194-009-0157-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTfelt-Hansen, Peer C | |
245 | 0 | 0 |
_aIs there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment. _h[electronic resource] |
260 |
_bThe journal of headache and pain _cDec 2009 |
||
300 |
_a389-91 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAzepines _xpharmacology |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
650 | 0 | 4 | _aCalcitonin Gene-Related Peptide Receptor Antagonists |
650 | 0 | 4 |
_aCerebral Arteries _xdrug effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDipeptides _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
650 | 0 | 4 | _aPiperazines |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 |
_aReceptors, Calcitonin Gene-Related Peptide _xmetabolism |
650 | 0 | 4 |
_aSerotonin Receptor Agonists _xpharmacology |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 |
_aTryptamines _xpharmacology |
773 | 0 |
_tThe journal of headache and pain _gvol. 10 _gno. 6 _gp. 389-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10194-009-0157-8 _zAvailable from publisher's website |
999 |
_c19176611 _d19176611 |